These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 5786067)

  • 1. The binding of steroids to plasma proteins in normal women and women with breast cancer.
    Wang DY; Bulbrook RD
    Eur J Cancer (1965); 1969 Jun; 5(3):247-53. PubMed ID: 5786067
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma concentrations of C-19 steroids, estrogens, FSH, LH and prolactin in post-menopausal women with an without breast cancer.
    Bird CE; Cook S; Owen S; Sterns EE; Clark AF
    Oncology; 1981; 38(6):365-8. PubMed ID: 6795556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine aspects of breast cancer.
    O'Higgins N
    Aust N Z J Surg; 1987 Oct; 57(10):697-701. PubMed ID: 3426443
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter: Oestrogen-binding protein in blood to predict response of breast cancer to hormone manipulation.
    Tisman G; Wu SJ
    Lancet; 1976 Jul; 2(7977):145-6. PubMed ID: 59207
    [No Abstract]   [Full Text] [Related]  

  • 5. Testosterone levels in the plasma of normal women and patients with benign breast disease or with breast cancer.
    Wang DY; Hayward JL; Bulbrook RD
    Eur J Cancer (1965); 1966 Dec; 2(4):373-6. PubMed ID: 5980828
    [No Abstract]   [Full Text] [Related]  

  • 6. No relationship between circulating levels of sex steroids and mammographic breast density: the Prospect-EPIC cohort.
    Verheus M; Peeters PH; van Noord PA; van der Schouw YT; Grobbee DE; van Gils CH
    Breast Cancer Res; 2007; 9(4):R53. PubMed ID: 17692133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma estrogens and androgens in male breast cancer.
    Calabresi E; De Giuli G; Becciolini A; Giannotti P; Lombardi G; Serio M
    J Steroid Biochem; 1976 Aug; 7():605-9. PubMed ID: 134178
    [No Abstract]   [Full Text] [Related]  

  • 8. Urinary and plasma androgens in benign breast disease. Possible relation to breast cancer.
    Brennan MJ; Wang DY; Hayward JL; Bulbrook RD; Deshpande N
    Lancet; 1973 May; 1(7812):1076-9. PubMed ID: 4122007
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum protein bound fucose in diagnosis of breast malignancy.
    Solanki RL; Ramdeo IN; Sachdev KN
    Indian J Med Res; 1978 May; 67(5):786-91. PubMed ID: 680922
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum concentrations of estrogens, sex hormone-binding globulin, and androgens and risk of breast cancer in postmenopausal women.
    Adly L; Hill D; Sherman ME; Sturgeon SR; Fears T; Mies C; Ziegler RG; Hoover RN; Schairer C
    Int J Cancer; 2006 Nov; 119(10):2402-7. PubMed ID: 16894564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid sex hormones and prolactin in postmenopausal women with generalized mammary carcinoma during prolonged dexamethasone treatment.
    Borkowski A; L'hermite M; Dor P; Longeval E; Rozencweig M; Muquardt C; Van Cauter E
    J Endocrinol; 1977 May; 73(2):235-46. PubMed ID: 140915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a breast cyst fluid protein detectable in the plasma of breast carcinoma patients.
    Haagensen DE; Mazoujian G; Holder WD; Kister SJ; Wells SA
    Ann Surg; 1977 Mar; 185(3):279-85. PubMed ID: 843124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of ACTH on aminoglutethimide induced reduction of plasma steroids in postmenopausal breast cancer.
    Bruning PF; Bonfrer JM; De Jong-Bakker M; Nooyen W
    J Steroid Biochem; 1984 Sep; 21(3):293-8. PubMed ID: 6092781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oestrogen binding and risk factors for breast cancer.
    Ingram DM; Nottage EM; Willcox DL; Roberts A
    Br J Cancer; 1990 Feb; 61(2):303-7. PubMed ID: 2310682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women.
    Hankinson SE; Willett WC; Manson JE; Colditz GA; Hunter DJ; Spiegelman D; Barbieri RL; Speizer FE
    J Natl Cancer Inst; 1998 Sep; 90(17):1292-9. PubMed ID: 9731736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma sex steroid hormones and breast cancer risk in Chinese women.
    Yu H; Shu XO; Shi R; Dai Q; Jin F; Gao YT; Li BD; Zheng W
    Int J Cancer; 2003 May; 105(1):92-7. PubMed ID: 12672036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk.
    Dorgan JF; Longcope C; Stephenson HE; Falk RT; Miller R; Franz C; Kahle L; Campbell WS; Tangrea JA; Schatzkin A
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):533-9. PubMed ID: 8827358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of levels of cytosol estrogen receptors with "arterial" and "venous" concentrations of gonadic steroids in mammary tumors.
    Duvivier J; Colin C; Hustin J; Albert A; Lavigne J; Dive G; Montfort F
    Clin Chim Acta; 1981 Apr; 112(1):21-32. PubMed ID: 7237822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-protein bound oestradiol, sex hormone binding globulin, breast cancer and breast cancer risk.
    Bruning PF; Bonfrèr JM; Hart AA
    Br J Cancer; 1985 Apr; 51(4):479-84. PubMed ID: 4038881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
    J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.